Evaluation of an ADAMTS13 activity ELISA

被引：0
|
作者：
Butler, J. [1 ]
Butler, J. J. [1 ]
Malan, E. [1 ]
Clifford, J. [1 ]
Wheeler, M. [1 ]
Gan, E. [1 ]
机构：
[1] Monash Med Ctr, Haematol, Melbourne, Australia
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-MO-713
引用
收藏
页码：563 / 563
页数：1
相关论文
共 50 条
  • [41] Comparative evaluation of the fully automated HemosIL® AcuStar ADAMTS13 activity assay vs. ELISA: possible interference by autoantibodies different from anti ADAMTS-13
    Falcinelli, Emanuela
    Baccolo, Andrea
    Mezzasoma, Anna Maria
    Gresele, Paolo
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (05) : E193 - E196
  • [42] Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies
    Palla, Roberta
    Valsecchi, Carla
    Bajetta, Mariateresa
    Spreafico, Marta
    De Cristofaro, Raimondo
    Peyvandi, Flora
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (02) : 381 - 385
  • [43] Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity
    Valsecchi, Carla
    Mirabet, Maribel
    Mancini, Ilaria
    Biganzoli, Marina
    Schiavone, Lucia
    Faraudo, Susanna
    Mane-Padros, Daniel
    Giles, David
    Serra-Domenech, Josep
    Blanch, Silvia
    Trisolini, Silvia Maria
    Facchini, Luca
    Rinaldi, Erminia
    Peyvandi, Flora
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (11) : 1767 - 1772
  • [44] EVALUATION OF THE FULLY AUTOMATED HEMOSIL® ACUSTAR ADAMTS13 ACTIVITY ASSAY.
    Favresse, Julien
    Lardinois, Benjamin
    Chatelain, Bernard
    Jacqmin, Hugues
    Mullier, Francois
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 : 39 - 39
  • [45] Spectrum of ADAMTS13 gene mutations in 19 patients with ADAMTS13 deficiency
    Calderzzo, J. C.
    Kempfer, A. C.
    Keller, L.
    Luceros, Sanchez A.
    Woods, A., I
    Powazniak, Y. P.
    Lazzari, M. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 656 - 656
  • [46] SNPs in ADAMTS13
    Tseng, Sandra Chang
    Kimchi-Sarfaty, Chava
    PHARMACOGENOMICS, 2011, 12 (08) : 1147 - 1160
  • [47] The carboxyl-terminal domains of ADAMTS13 cause substrate-dependent divergence of ADAMTS13 activity.
    Zhou, Wenhua
    Tsai, Han-Mou
    BLOOD, 2006, 108 (11) : 117A - 117A
  • [48] Persistent reduction of ADAMTS13 activity in acute ischemic stroke which is independent of VWF levels and ADAMTS13 inhibitor
    Baker, R., I
    Thom, J.
    Hughes, Q.
    Plaimauer, B.
    Scheiflinger, F.
    Rottensteiner, H.
    Hankey, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 732 - 733
  • [49] Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP
    Saito, Kenki
    Sakai, Kazuya
    Kubo, Masayuki
    Azumi, Hidekazu
    Hamamura, Atsushi
    Ochi, Shinichi
    Amagase, Hiroki
    Kunieda, Hisako
    Ogawa, Yoshiyuki
    Yagi, Hideo
    Matsumoto, Masanori
    BLOOD ADVANCES, 2024, 8 (09) : 2151 - 2159
  • [50] Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor:: in vitro inhibition of ADAMTS13 activity by hemoglobin
    Studt, JD
    Hovinga, JAK
    Antoine, G
    Hermann, M
    Rieger, M
    Scheiflinger, F
    Lämmle, B
    BLOOD, 2005, 105 (02) : 542 - 544
12345